Syntax, a leading global technology solutions provider driving enterprise transformation in the cloud, today announced the launch of its AI-First Application Managed Services (AMS)—a next-generation ...

Syntax, a leading global technology solutions provider driving enterprise transformation in the cloud, today announced a new GenAI-powered migration offering designed to help organizations accelerate ...

Cell therapies are already here, with treatments now available for some cancers and rare diseases. But bringing such living medicines to more patients presents both scientific and financial challenges ...

The transformation created a digital core for Rio2, replacing manual processes with integrated SAP Cloud ERP solutions.

The Science Advances publication details Cellgorithm™, a CRISPR-based technology that gives researchers greater control over gene activity and sets the stage for future applications in stem cell ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of new research in Science Advances detailing the company's CRISPR-based ...